Sigyn Therapeutics, Inc. (SIGY) › Shares OutstandingSigyn Therapeutics, Inc. (SIGY) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2014: 16.00M2015: 34.32M2017: 53.28M2018: 81.27M2019: 500.0K2020: 35.20M2021: 37.30M2022: 956.6K2023: 1.29M2024: 1.61M1.61M2014Shares Outstanding (shares)2024Fiscal YearShares OutstandingChange YoY20241.61M+24.6%20231.29M+34.7%2022956.6K-97.4%202137.30M+5.9%202035.20M+6940.3%2019500.0K-99.4%201881.27M+52.5%201753.28M—201534.32M+114.5%201416.00M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share